The most well-studied promoter modules that control the specific expression of the therapeutic gene in melanoma cells, with recent widespread application, are promoters of the tyrosinase gene ( TYR ) or the gene encoding the melanoma inhibitory activity ( MIA ), sometimes combined with distal elements of other promoters and/or the enhancers [21, 22]. Here, TYR is linked to melanoma.